NOVELIX PHARMACEUTICALS
Smallcap | BSE
Sector
Here's the live share price of Novelix Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.72₹ 0.55
As on Sep 07, 2026, 04:01 PM IST
Source: Dion Global
Novelix Pharmaceuticals Price Performance
Today's LowToday's High
₹77.10₹80.35
₹77.10
52 Weeks' Low52 Weeks' High
₹38.00₹92.00
₹77.10
Open Price
₹78.10
Prev. Close
₹76.55
Volume
5,189
Source: Dion Global
Novelix Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Novelix Pharmaceuticals | -5.86 | 9.36 | 17.71 | 40.18 | 97.69 | 109.71 | 57.44 |
| Sun Pharmaceutical Industries | -1.06 | -2.52 | 6.52 | 6.56 | 19.13 | 18.83 | 19.37 |
| Divi's Laboratories | 0.39 | 11.44 | 40.48 | 46.22 | 54.84 | 36.71 | 12.32 |
| Torrent Pharmaceuticals | -2.42 | -1.70 | 11.19 | 12.86 | 37.24 | 37.92 | 25.70 |
| Zydus Lifesciences | -2.70 | 3.96 | 6.07 | 26.31 | 13.89 | 22.15 | 15.71 |
| Cipla | -1.56 | -3.73 | -0.34 | 5.28 | -10.13 | 4.07 | 7.99 |
| Laurus Labs | -3.46 | 1.39 | 29.11 | 78.63 | 112.05 | 66.28 | 23.12 |
| Aurobindo Pharma | 0.48 | 2.76 | 13.36 | 35.26 | 58.75 | 24.79 | 17.03 |
| Lupin | -3.22 | -11.78 | -7.19 | -9.75 | 8.25 | 23.44 | 16.46 |
| Mankind Pharma | -2.74 | -5.30 | -0.64 | 4.34 | -8.99 | 9.46 | 10.27 |
| Dr. Reddy's Laboratories | -2.78 | -2.47 | -10.39 | -12.80 | -9.74 | 0.87 | 3.10 |
| Glenmark Pharmaceuticals | -2.20 | 9.52 | 13.69 | 16.67 | 19.89 | 45.83 | 35.65 |
| Biocon | -4.35 | -7.41 | -4.50 | 1.78 | 8.16 | 13.79 | 1.72 |
| Alkem Laboratories | -3.18 | -8.53 | -1.36 | -6.57 | -2.93 | 12.41 | 6.25 |
| Abbott India | -1.88 | -6.97 | -0.84 | -6.51 | -17.25 | 4.21 | 5.63 |
| Anthem Biosciences | 3.71 | 13.11 | 22.58 | 40.17 | 12.56 | 8.54 | 5.04 |
| GlaxoSmithKline Pharmaceuticals | -4.38 | 15.72 | 37.10 | 19.85 | 7.21 | 26.82 | 14.65 |
| Ipca Laboratories | 0.53 | 10.99 | 19.35 | 30.75 | 46.87 | 30.02 | 9.44 |
| Gland Pharma | 2.98 | 16.75 | 30.80 | 74.32 | 56.96 | 20.62 | -5.73 |
| Ajanta Pharma | -1.51 | 1.94 | 17.72 | 17.85 | 34.16 | 27.05 | 18.91 |
Source: Dion Global
Over the last one year, Novelix Pharmaceuticals has gained 97.69% compared to peers like Sun Pharmaceutical Industries (19.13%), Divi's Laboratories (54.84%), Torrent Pharmaceuticals (37.24%). From a 5 year perspective, Novelix Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (19.37%) and Divi's Laboratories (12.32%).
Novelix Pharmaceuticals Financials
Source: Dion Global
Novelix Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 79.56 | 78.88 |
| 10 | 80.23 | 79.03 |
| 20 | 77.85 | 77.71 |
| 50 | 73.74 | 74.21 |
| 100 | 67.92 | 69.68 |
| 200 | 63.11 | 62.34 |
Source: Dion Global
Novelix Pharmaceuticals Share Holding Pattern
In the latest quarter, Novelix Pharmaceuticals saw a rise in promoter holding to 54.29%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 45.69% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Novelix Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Aug 31, 2026, 06:07 AM IST IST | Novelix Pharma. - Shareholders Meeting AGM On 30Th September, 2026. |
| Aug 31, 2026, 06:05 AM IST IST | Novelix Pharma. - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Aug 29, 2026, 11:32 PM IST IST | Novelix Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 29Th August, 2026 |
| Aug 25, 2026, 11:38 PM IST IST | Novelix Pharma. - Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Saturday, 29Th August, 2026 |
| Aug 20, 2026, 06:52 PM IST IST | Novelix Pharma. - Announcement Under Regulation 30 (LODR) - Lease Deed |
Source: Dion Global
About Novelix Pharmaceuticals
Novelix Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 21/10/1993 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L67120TG1994PLC018956 and registration number is 018956. Currently Company is involved in the business activities of Manufacture of macaroni, noodles, couscous and similar farinaceous products. Company's Total Operating Revenue is Rs. 132.31 Cr. and Equity Capital is Rs. 21.09 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressAmrutha Estates, 6th floor, H.No. 3-6-237/610, Hyderabad Telangana 500029
- Contact
Source: Dion Global
Management
- Mrs. Monam KapoorInd. Non-Executive Director
- Mr. Venkateshwarlu PulluruWhole Time Director
- Mr. Janardhan Das KabraInd. Non-Executive Director
- Mr. Gattu Gnana PrakashInd. Non-Executive Director
- Mr. Jivamohan Divakar ValluriNon Exe.Non Ind.Director
- Mr. Lakshman SamalaInd. Non-Executive Director
- Ms. Mayuri BaidyaInd. Non-Executive Director
FAQs on Novelix Pharmaceuticals Share Price
What is the share price of Novelix Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Novelix Pharmaceuticals is ₹77.10 as on Sep 07, 2026.
What kind of stock is Novelix Pharmaceuticals?
The Novelix Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Novelix Pharmaceuticals?
The market cap of Novelix Pharmaceuticals is ₹62.45 Cr as on Sep 07, 2026.
What are today's High and Low prices of Novelix Pharmaceuticals?
Today’s highest and lowest price of Novelix Pharmaceuticals are ₹80.35 and ₹77.10.
What are the 52 Week High and 52 Week Low of Novelix Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Novelix Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Novelix Pharmaceuticals is ₹92.00 and 52-week low of Novelix Pharmaceuticals is ₹38.00 as on Sep 07, 2026.
How has the Novelix Pharmaceuticals performed historically in terms of returns?
The Novelix Pharmaceuticals has shown returns of 0.72% over the past day, 9.36% for the past month, 17.71% over 3 months, 97.69% over 1 year, 109.71% across 3 years, and 57.44% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Novelix Pharmaceuticals?
P/E ratio of and PB ratio of Novelix Pharmaceuticals are -27.02 and 8.43 on Sep 07, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕